Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Poonam K. Neki, MBBS,DA, CCRP
Research Director
Baptist MD Anderson Clinical Trials
904.202.7468
poonam.neki@bmcjax.com
Clinical Trial ID: NCT05079230
A Phase III, Randomized Double-Blind, Placebo-controlled Study Evaluating the Safety and Efficacy of Magrolimab versus Placebo in Combination with Venetoclax and Azacitidine in Newly Diagnosed, Previously untreated Patients with Acute Myeloid Leukemia Who are ineligible for Intensive Chemotherapy
Status
Open
Conditions
Other
Phases
III
Age Group
Adult
Main Investiagtor
Norkin, Maxim
Practice
Heme
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT05079230
Secondary Trial ID Number
GS-US-590-6154
Keywords
Treatment